Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof

A compound of Formula (I):

• wherein:
• X is NH or O;
• R1 is selected from the group consisting of H, halogen, hydroxy, thioxy, cyano, nitro, C1-4 haloalkyl, amino, C1-4 alkylamino, C2-8 dialkylamino, C1-4 alkyl, C1-4 alkoxy, C2-4 alkenyl, C2-4 alkynyl, C3-5 cycloalkyl, C1-4 haloalkoxy, C1-4 alkylthio, C1-4 alkylsulfinyl, C1-4 alkylsulfonyl, C1-4 haloalkylthio, C1-4 haloalkylsulfinyl and C1-4 haloalkylsulfonyl;
• R2 is selected from the group consisting of H, halogen, hydroxy, thioxy, cyano, nitro, C1-4 haloalkyl, amino, C1-4 alkylamino, C2-8 dialkylamino, C1-4 alkyl, C1-4 alkoxy, C2-4 alkenyl, C2-4 alkynyl, C3-5 cycloalkyl, C1-4 haloalkoxy, C1-4 alkylthio, C1-4 alkylsulfinyl, C1-4 alkylsulfonyl, C1-4 haloalkylthio, C1-4 haloalkylsulfinyl and C1-4 haloalkylsulfonyl;
• or R2 is absent;
• is a single bond when R2 is present, or is a double bond when R2 is absent;
• and
• Ring A is a 5, 6 or 7-membered carbocyclic ring or a 5, 6 or 7-membered heterocyclic ring optionally substituted with 1 to 4 substituents selected from the group consisting of halogen, hydroxy, thioxy, cyano, nitro, C1-4 haloalkyl, amino, C1-4 alkylamino, C2-8 dialkylamino, C1-4 alkyl, C1-4 alkoxy, C2-4 alkenyl, C2-4 alkynyl, C3-5 cycloalkyl, C1-4 haloalkoxy, C1-4 alkylthio, C1-4 alkylsulfinyl, C1-4 alkylsulfonyl, C1-4 haloalkylthio, C1-4 haloalkylsulfinyl and C1-4 haloalkylsulfonyl;
• or
• a pharmaceutically acceptable salt, solvate or hydrate thereof.